Patents by Inventor Sajni Josson

Sajni Josson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Targeting microRNA miR-409-3P to treat prostate cancer
    Patent number: 9745578
    Abstract: The present invention describes methods of treating cancer, cancer metastasis, and drug resistant cancers using miRNA inhibitors; for example, inhibitors of miR-409-5p, miR-409-3p, miR-154*. Also described are methods of using the miRNA as biomarkers; for example, to predict responsiveness to a cancer drug, to detect a disease state of cancer.
    Type: Grant
    Filed: September 24, 2015
    Date of Patent: August 29, 2017
    Assignee: CEDARS-SINAI MEDICAL CENTER
    Inventors: Leland W. K. Chung, Sajni Josson, Murali Gururajan, Anjali Jain
  • TARGETING MICRORNAS MIR-409-5P, MIR-409-3P AND MIR-154* TO TREAT PROSTATE CANCER BONE METASTASIS AND DRUG RESISTANT LUNG CANCER
    Publication number: 20160017331
    Abstract: The present invention describes methods of treating cancer, cancer metastasis, and drug resistant cancers using miRNA inhibitors; for example, inhibitors of miR-409-5p, miR-409-3p, miR-154*. Also described are methods of using the miRNA as biomarkers; for example, to predict responsiveness to a cancer drug, to detect a disease state of cancer.
    Type: Application
    Filed: September 24, 2015
    Publication date: January 21, 2016
    Applicant: CEDARS-SINAI MEDICAL CENTER
    Inventors: Leland W.K. Chung, Sajni Josson, Murali Gururajan, Anjali Jain
  • TARGETING MICRORNAS MIR-409-5P, MIR-379 AND MIR-154* TO TREAT PROSTATE CANCER BONE METASTASIS AND DRUG RESISTANT LUNG CANCER
    Publication number: 20140323551
    Abstract: The present invention describes methods of treating cancer, cancer metastasis, and drug resistant cancers using miRNA inhibitors; for example, inhibitors of miR-409-5p. Also described are methods of using the miRNA as biomarkers; for example, to predict responsiveness to a cancer drug, to detect a disease state of cancer.
    Type: Application
    Filed: November 30, 2012
    Publication date: October 30, 2014
    Applicant: CEDARS-SINAI MEDICAL CENTER
    Inventors: Leland W.K. Chung, Sajni Josson, Murali Gururajan, Anjali Jain
  • ANTI-BETA-2-MICROGLOBULIN AGENTS AND THE USE THEREOF
    Publication number: 20110142848
    Abstract: A method for treating cancer includes treating a subject with an agent against beta-2-microglobulin; and treating the subject with radiation or a cancer therapeutic agent. The agent against beta-2-microglobulin includes anti-b2-M antibodies and miRNAs.
    Type: Application
    Filed: August 7, 2009
    Publication date: June 16, 2011
    Inventors: Leland W.K. Chung, Sajni Josson, Wen-Chin Huang, Haiyen E. Zhau